» Articles » PMID: 38545101

Applications of Emerging Extracellular Vesicles Technologies in the Treatment of Inflammatory Diseases

Overview
Journal Front Immunol
Date 2024 Mar 28
PMID 38545101
Authors
Affiliations
Soon will be listed here.
Abstract

The emerging extracellular vesicles technologies is an advanced therapeutic approach showing promising potential for addressing inflammatory diseases. These techniques have been proven to have positive effects on immune modulation and anti-inflammatory responses. With these advancements, a comprehensive review and update on the role of extracellular vesicles in inflammatory diseases have become timely. This review aims to summarize the research progress of extracellular vesicle technologies such as plant-derived extracellular vesicles, milk-derived extracellular vesicles, mesenchymal stem cell-derived extracellular vesicles, macrophage-derived extracellular vesicles, etc., in the treatment of inflammatory diseases. It elucidates their potential significance in regulating inflammation, promoting tissue repair, and treating diseases. The goal is to provide insights for future research in this field, fostering the application and development of extracellular vesicle technology in the treatment of inflammatory diseases.

References
1.
Kamerkar S, LeBleu V, Sugimoto H, Yang S, Ruivo C, Melo S . Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017; 546(7659):498-503. PMC: 5538883. DOI: 10.1038/nature22341. View

2.
Chen L, Lu F, Chen D, Wu J, Hu E, Xu L . BMSCs-derived miR-223-containing exosomes contribute to liver protection in experimental autoimmune hepatitis. Mol Immunol. 2017; 93:38-46. DOI: 10.1016/j.molimm.2017.11.008. View

3.
Del Pozo-Acebo L, Lopez de Las Hazas M, Tome-Carneiro J, Gil-Cabrerizo P, San-Cristobal R, Busto R . Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy. Int J Mol Sci. 2021; 22(3). PMC: 7865385. DOI: 10.3390/ijms22031105. View

4.
El Andaloussi S, Mager I, Breakefield X, Wood M . Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013; 12(5):347-57. DOI: 10.1038/nrd3978. View

5.
Wang Y, Qiu Z, Yuan J, Li C, Zhao R, Liu W . Hypoxia-reoxygenation induces macrophage polarization and causes the release of exosomal miR-29a to mediate cardiomyocyte pyroptosis. In Vitro Cell Dev Biol Anim. 2021; 57(1):30-41. DOI: 10.1007/s11626-020-00524-8. View